pharmaceuticsArticleEV20/NMS-P945, a Novel Thienoindole Based Antibody-DrugConjugate Targeting HER-3 for Solid TumorsEmily Capone1,2, Rossano Lattanzio1,2, Fabio Gasparri3 , Paolo Orsini 3 , Cosmo Rossi 2 , Valentina Iacobelli 4 ,Vincenzo De Laurenzi1,2 , Pier Giorgio Natali 5 , Barbara Va...
EV20/NMS-P945, a novel Thienoindole based antibody-drug conjugate targeting HER-3 for solid tumors Pharmaceutics, 13 (2021), 10.3390/pharmaceutics13040483 Google Scholar [15] L. Gandullo-Sanchez, et al. HER3 targeting with an antibody-drug conjugate bypasses resistance to anti-HER2 therapies EM...